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Globoid cell leukodystrophy (GLD) is a rapidly progressing pediatric neurodegenerative disease caused by missing
or dysfunctional lysosomal enzyme galactosylceramidase
(GALC). Hallmarks of this disease include macrophage
(globoid cell) infiltration into the brain parenchyma, loss
and dysfunction of myelin and oligodendrocytes, and axonal damage (1, 2). The GALC enzyme is responsible for
cleaving the glycosydic linkage of galactosylceramide and
galatosylsphingosine (psychosine or psy) (3). Although galactosylceramide can be degraded by other enzymes, psy
cannot and subsequently accumulates to high levels in the
brains of GALC-deficient individuals (4).
Psychosine is a highly cytotoxic lipid, capable of inducing cell death in a wide variety of cell types including, most
relevantly to GLD, oligodendrocytes (5). Psychosine accumulation was postulated to be the pathogenic mechanism
leading to GLD nearly 40 years ago (4, 6, 7). However, the
mechanism of psychosine toxicity has remained elusive
(8). Psychosine induces pleiotropic effects, including dysfunctions in several cellular pathways and compartments
with no clear mechanistic connection between them (9–13).
No unified cause for these dysfunctions has been proposed.
Given the wide-ranging nature of psy’s effects, it seems unlikely that psy toxicity is mediated through a single proteinbinding partner, such as a receptor. It is similarly unlikely
that psy specifically binds many proteins independently.
As an amphipathic molecule, psy would be expected to
partition largely into cellular membranes. Indeed, White
et al. (14) demonstrated that psy preferentially partitions
into detergent-resistant membrane microdomains rich in
cholesterol. Cholesterol has a chemical affinity for sphingolipids such as psy (15); therefore, this association is not
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Abstract Globoid cell leukodystrophy (GLD) is a neurological disease caused by deficiency of the lysosomal enzyme
galactosylceramidase (GALC). In the absence of GALC, the
cytotoxic glycosphingolipid, psychosine (psy), accumulates
in the nervous system. Psychosine accumulation preferentially
affects oligodendrocytes, leading to progressive demyelination and infiltration of activated monocytes/macrophages
into the CNS. GLD is characterized by motor defects, cognitive deficits, seizures, and death by 2–5 years of age. It has
been hypothesized that psychosine accumulation, primarily
within lipid rafts, results in the pathogenic cascade in GLD.
However, the mechanism of psychosine toxicity has yet to
be elucidated. Therefore, we synthesized the enantiomer of
psychosine (ent-psy) to use as a probe to distinguish between
protein-psy (stereo-specific enantioselective) or membranepsy (stereo-insensitive nonenantioselective) interactions.
The enantiomer of psychosine has equal or greater toxicity
compared with psy, suggesting that psy exerts its toxicity
through a nonenantioselective mechanism. Finally, in this
study we demonstrate that psy and ent-psy localize to lipid
rafts, perturb natural and artificial membrane integrity, and
inhibit protein Kinase C translocation to the plasma membrane. Although other mechanisms may play a role in disease, these data strongly suggest that psy exerts its effects
primarily through membrane perturbation rather than through
specific protein-psy interactions.—Hawkins-Salsbury, J.A.,
A.R. Parameswar, X. Jiang, P.H. Schlesinger, E. Bongarzone,
D.S. Ory, A.V. Demchenko, and M.S. Sands. Psychosine, the
cytotoxic sphingolipid that accumulates in globoid cell leukodystrophy, alters membrane architecture. J. Lipid Res.
2013. 54: 3303–3311.

MATERIALS AND METHODS

exposed to the lipids for 24 h before measuring cell survival. Cell
viability was measured using the commercially available MTT assay
(ATCC, Manassas, VA). This procedure is based on the cleavage
of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
to a blue product by mitochondrial dehydrogenase in viable cells.
Absorbance was measured at 570 nm and compared with the reference wavelength of 650 nm to determine cell viability. Cell survival after lipid treatment was normalized to the vehicle (DMSO)
control.

Psy- and ent-psy-mediated apoptosis
The proportion of cells undergoing apoptosis mediated by exposure to psy or its ent-psy was measured using Annexin V according to the manufacturer’s instructions. Briefly, oligodendrocyte
cells, M03.13, were plated at ⵑ80% confluence on day 1. The
cells were serum-starved for 24 h, and then the appropriate concentration (10, 20, and 40 M) of psychosine or the enantiomer
was added for an additional 24 h in the absence of fetal calf serum. The cells were harvested, washed once in PBS, and resuspended at ⵑ1 × 106 cells/ml in Annexin V binding buffer (10 mM,
HEPES [7.4], 140 mM NaCl, 2.5 mM CaCl2). Allophycocyaninconjugated Annexin V (cat# A35110; Life Technologies, Eugene,
OR) and 7AAD (viability) were added to the cell suspensions and
incubated 15 min at room temperature. The Annexin V-positive
cells were detected by fluorescence activated cell sorting using a
Beckman Coulter Gallios instrument (Brea, CA) and analyzed
using FloJo software (Ashland, OR).

Psy and ent-Psy degradation
MO3.13 cells were pulsed with 10 M psy, ent-psy or an equivalent volume of vehicle for 30 min, after which they were washed
and returned to normal media at 37°C. At 0, 15, 30, and 60 min
postpulse, cells were washed, harvested, spun down, and flash
frozen. Once thawed, cells were quickly homogenized in 0.04 M
citric acid by passing five times through a 25 gauge needle . Fifty
microliters of each sample was added to 20 l of N,N-dimethylpsychosine (250 ng/ml) internal standard and 200 l MeOH.
Samples were vortexed and centrifuged, and the supernatant was
collected. This extraction was repeated on the remaining pellet
and the supernatants pooled. Psy or ent-psy concentrations were
obtained using a column-switching LC-MS/MS method. Detection was achieved using an AB SCIEX 4000QTRAP tandem mass
spectrometer (Applied Biosystems/MDS Sciex Inc., Ontario,
Canada) using ESI in the positive ion mode along with multiple
reaction monitoring. Analyst software (version 1.5.1; Applied
Biosystems/MDS Sciex Inc.) was used for the data analysis. The
calibration curves (analyte peak area/internal standard peak area
for y-axis and analyte concentration for x-axis) of psychosine were
obtained using the least square linear regression fit (y = ax + b)
and a weighting factor of 1/x2. The coefficient of determination
(r2) was set as >0.98 for acceptance criteria of calibration curves.

Chemicals and reagents ent

Immunocytochemistry

Psychosine was synthesized as previously described (23) Psychosine was obtained from Matreya (Pleasant Gap, PA). Both lipids were dissolved in DMSO to 20 mM before use unless otherwise
noted.

HeLa cells were plated at a density of 2 × 104 cells/cm2 on polyL-lysine (Sigma, St. Louis MO) coated glass coverslips in serumfree standard media (DMEM-F12). After 24 h of growth, the cells
were exposed to lipids or vehicle for an additional 24 h. After this
time, stimulated cells were treated with 20 ng/ml platelet-derived
growth factor for 15 min at 37°C. After stimulation, the cells were
fixed with 4% paraformaldehyde. Plasma membranes were
stained with fluorescently labeled cholera toxin B (CTXB, Sigma)
before incubation with anti-phosphoPKC primary antibody (Cell
Signaling, Danvers, MA). After incubation with secondary antibodies (Invitrogen, Grand Island, NY), the coverslips were
mounted and imaged with a Zeiss confocal microscope in the

Cell viability measurements
Cells from the human glial (oligodendrocytic) cell line MO3.13
(Cedarlane Labratories, Burlington, NC) were maintained in
DMEM with 10% FBS. Before lipid treatment, cells were plated to
a density of 2 × 104 cells/cm2 on uncoated plastic dishes. After 24 h,
the media was replaced with serum-free media. After an additional
24 h, media containing lipids or vehicle was added. Cells were
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surprising. It is possible that psy disrupts the biophysical
properties of membranes it inserts into, thereby causing
widespread downstream effects. Membrane perturbations have been implicated in other diseases, including
Alzheimer’s (16), cancer (17), and diabetes (18), providing evidence that this mechanism is possible and perhaps
even common.
Enantiomers are powerful tools with which to investigate
biological processes (19). Enantioselectivity has recently
been used to distinguish between the protein-mediated
and membrane-mediated effects of cholesterol and other
steroids (20–22). Similarly, enantioselectivity can be used
to study psy modes of action. Enantiomers (psy and ent-psy) have identical physicochemical properties but are
mirror images of each other. Typically, only one enantiomer
of lipids, proteins, sugars, nucleic acids, and cofactors are
found within cells. Proteins are chiral molecules with a defined three-dimensional structure and generally only recognize one enantiomer of their binding partners (psy or
ent-psy) (19). Accordingly, psy interactions with proteins
are expected to be largely enantioselecitve. Conversely, the
lipid membrane, even though it is composed of chiral molecules, is fluid and does not maintain well-defined “binding sites” for other lipids or sterols. Thus, lipid-lipid and
lipid-sterol membrane interactions of psy are nonenantioselective. Additionally, any membrane property altered
by psy (i.e., polarity, fluidity, and packing capacity) will be
altered equivalently by ent-psy because of its identical
chemical and physical properties. This point is important
because if psy and ent-psy had different physicochemical
properties then they might alter membrane properties differently even if their membrane interactions were not
enantioselective. Because of this fundamental difference
between membranes and proteins, protein-mediated actions are usually enantiosensitive, whereas membranemediated actions are not. Therefore, enantiomers of natural
molecules can be used as probes to distinguish between
enantio-specific (protein-mediated) and nonenantio-specific
(lipid membrane-based) functions (19). We previously synthesized the unnatural enantiomer of psy (ent-psy) (23). In
this study, the underlying causes of psy toxicity are investigated using ent-psy as a probe to distinguish between protein- and membrane-based mechanisms.

Alafi Neuroimaging Core (Washington University in St. Louis,
Hope Center). Images from random fields were acquired. Membrane translocation was quantified by an independent observer
blinded to treatment who scored each cell as “membrane associated” or “cytoplasmic.” More than 30 cells per treatment were
scored in this manner.

Liposome preparation
Carboxyfluorescein (CF)-loaded DOPC (Sigma) liposomes were
generated essentially as previously described (24). Dried DOPC
was dissolved in 0.5 ml ethyl ether, and an equal volume of 20 mM
CF (Molecular Probes, Eugene, OR) in elution buffer (100 mM
KCl, 10 mM HEPES [pH 7.0], 1 mM EDTA) was added. This mixture was sonicated three times for 20 s each to generate a thick
emulsion before evaporation of the ether under reduced pressure. The evaporated solution was passed five times through a 22
guage needle and a mini-extruder (Avanti, Alabaster, AL) containing a 200 nM membrane to limit liposome size (Nuclepore,
Pleasanton, CA). All CF not contained within a liposome was
removed by passing the solution over a Sephadex G-25-80 column. Liposome concentration was normalized against the maximum fluorescence achieved after the vesicles were lysed with
20% Triton-X-100.

Liposomes were diluted in elution buffer to a concentration
appropriate for the assay (generally 1:500 to 1:2,000) to a final
volume of 1 ml. Baseline fluorescence was measured for 10 min.
Lipids were then added, and the change in fluorescence was
measured for an additional 60 min. At this time, 10 l of 20%
Triton-X-100 was added to lyse all liposomes so that the maximal
fluorescence could be obtained. Data are presented as the percent maximal fluorescence after the baseline is subtracted.

Detergent-resistant membrane composition
Detergent-resistant membranes (DRMs) were isolated and analyzed essentially as previously reported (14). Briefly, HeLa cells
were treated with lipid at a concentration of 10 M for 6 h. The
cells were scraped from the plates, pelleted, then resuspended in
2 ml cold lysis buffer (25 mM Tris-HCL [pH 7.4], 150 mM NaCl,
5 mM EDTA, 0.5% Lubrol, protease inhibitor cocktail, 1 mM
PMSF, 1 mM okadaic acid, and 2 mM sodium orthovanadate).
This suspension was passed through a 25 gauge needle five times
to lyse the cells. An equal volume of 90% sucrose was added to
the cellular lysate to give a final concentration of 45% sucrose.
Four milliliters of 35% sucrose then 5% sucrose was loaded on
top of the homogenates using an auto densi-flow density gradient
fractionator (Labonco, Kansas City, MO). Tubes were ultracentrifuged using a SW-41 rotor (Beckman-Coulter, Brea, CA) at
39,000 rpm overnight at 4°C. Fractions were collected in 1ml volumes from the top of the fractions down, with raft markers found
in fractions 4 and 5. Psy or ent-psy was measured using LC-MS. To
prepare the samples, each fraction was extracted with chloroform/methanol/water then analyzed as described (25). Positive
ion electrospray precursor ion scanning was performed using a
triple quadrapole mass spectrometer (API 4000, Applied Biosystems) equipped with a Shimadzu HPLC system and Leap autosampler (26). Ceramide was quantified in these samples using an
AB SCIEX 4000QTRAP tandem mass spectrometer (Applied
Biosystems/MDS Sciex Inc.).

Western blot of membrane fractions
Western blots of membrane fractions were carried out essentially as described previously (14). Pooled aliquots from DRMs
(fractions 4 and 5) were solubilized in 0.25% SDS. Volume of

Cholesterol extractability with cyclodextrin
CHO cells were grown on uncoated plastic dishes under standard conditions in DMEM-F12 media containing 5% FBS. Twenty-four hours before testing, cells were loaded with 1 Ci/ml
3
H-Cholesterol (PerkinElmer, Waltham, MA). At this time, cells
were also treated with 20 M lipids or vehicle control. After 24 h,
the media was washed off, and cells were trypsinized and pelleted. The cell pellet was washed three times with HEPES/DMEM
(50 mM HEPES in DMEM) to remove any remaining 3H-cholesterol and resuspended in HEPES/DMEM at 4 × 106 cells/ml. Six
hundred microliters of this cell suspension was added to 3 ml
acceptor medium (50 ml 2-hydroxypropyl-␤-cyclodextrin in
HEPES/DMEM 50% cholesterol saturated) and incubated at
37°C. Aliquots (200 l) were removed after 0, 0.5, 1, 2, 4, 6, 10,
and 20 min. These aliquots were filtered to remove the cells, and
the flow-through containing CD-extracted 3H-cholesterol was collected. The amount of 3H-cholesterol in the samples was measured by scintillation counting and normalized to the time zero
measurement. Control samples were treated with lyso-phosphatidylserine (25 M; decreases cholesterol extractability), 25-hydroxycholesterol (1 M; increases cholesterol extractability), or
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (1 M; has no
effect on cholesterol extractability).

Statistical analysis
Graphpad Prism software (GraphPad Software, Inc., La Jolla,
CA) was used to generate all graphs and perform all statistical
analyses. All data are the average of at least three experiments
and are presented as the mean ± SEM unless otherwise noted.
Student’s t-tests, one-way ANOVA, or repeated measures ANOVA
were used where appropriate. P values <0.05 were considered
significant.

RESULTS
Ent-psy-protein interactions
We first confirmed that ent-psy (Fig. 1A) could not interact with the only known psy-binding protein, GALC, as predicted. We measured the degradation of psy and ent-psy
over time in MO3.13 cells (which have functional GALC).
Whereas psy was rapidly degraded to a steady-state level
after 1 h, levels of ent-psy remained high over this time
course (Fig. 1B). Therefore, GALC does not recognize and
degrade ent-psy. These data also clearly demonstrate that
exogenously added lipid does enter cells and lysosomes
because it could not otherwise be available to the lysosomal enzyme GALC for degradation.
Cell viability
The oligodendrocytic cell line MO3.13 has been used frequently for psy-toxicity studies. After a 24-hr serum-starvation,
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Liposome swelling

sample loaded was normalized, and samples were resolved in a
precast 7.5% polyacrylamide gel (Biorad, Hercules, CA) using the
MiniProtean electrophoresis system (Biorad). Proteins were then
transferred to a PVDF membrane (Biorad), blocked with 5%
nonfat milk, and probed with primary antibodies for phosphoPKC (Cell Signaling) or total PKC (Santa Cruz Biotechnology,
Santa Cruz, CA). After incubation with peroxidase-labeled secondary antibodies, the blots were visualized with chemiluminescent
ECL substrate (Pierce, Rockford, IL). All treatment groups (DMSO,
psy, and ent-psy) were exposed to the same film for the same
amount of time. Signal was quantified using ImageJ software.

these cells were treated with psy, ent-psy, or vehicle (DMSO)
at a lethal (20 M) or sublethal (5 M) dose. These concentrations were empirically determined. Psy at 20 M has
been shown to be toxic, and a dose response curve revealed
that 5 M is not. After 24 h, cell viability was assessed (Fig. 2A).
As expected, neither psy nor ent-psy demonstrated toxicity
at 5 M. Both lipids were highly cytotoxic at 20 M, showing only 20–30% cell viability after 24 h. At concentrations
higher than 20 M, 0% cell viability was observed. A small
but significant increase in toxicity of ent-psy relative to psy
was observed.
Psy- and Ent-Psy-mediated apoptosis
Psychosine causes cell death at least in part via apoptosis
(10, 27, 28). It was theoretically possible that psy and ent-psy
could cause cell death through different mechanisms.
To investigate this, we treated cells with psy or ent-psy and
measured the percentage of cells staining positively for the
apoptosis marker Annexin V. Treatment with either lipid resulted in a dose-dependent increase in Annexin V-positive
cells, and both lipids induced apoptosis equivalently (Fig. 2B).
Therefore, not only is psy toxicity not enantioselective, but
both enantiomers likely induce death through the same
mechanism(s).
Translocation of PKC
Protein kinase C is an important signal transduction
protein involved in regulating numerous cellular functions.
Psychosine is a known inhibitor of PKC. White et al. (14)
demonstrated that phosphorylated PKC (p-PKC, active)
does not translocate to the plasma membrane of cells
treated with psy under PKC stimulating conditions. However,
3306
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it was unclear whether this is due to direct binding of psy
to either of PKC’s lipid-binding domains. Phospholipid
binding is required for PKC translocation to the membrane
and function. Although it is unlikely that psy would bind
in a pocket optimized for phospholipids, it is possible that
psy may be able to aberrantly enter the lipid-binding site
of PKC. It is equally possible that psy may act by altering
the plasma membrane in such a way as to exclude PKC association without binding to PKC. To test this, we treated
cells with psy or ent-psy to determine whether psy bound to
PKC directly because ent-psy should not be capable of such
an interaction. The lipid-binding domain of PKC is stereospecific and would be predicted not to recognize the
enantiomer of a lipid binding partner (29). We observed
that psy and ent-psy inhibit the translocation of PKC to the
membrane surface under stimulating conditions (Fig. 3).
Previously, activated PKC (p-PKC) has been shown to be
diminished at the DRMs in the brains of Twi mice compared with normal animals (14). Significantly less p-PKC is
found associated with the DRM fraction of psy or ent-psy
treated cells, so this inhibition of association, even in an
unstimulated cell, is nonenantioselective. These data suggest that psy inhibition of PKC is most likely due to an alteration of the lipid environment rather than a direct
binding of psy to PKC itself.
Liposome swelling
To further investigate what effects psy may have on
membranes, we used a liposome-based system. Disruptive
lipids cause the liposomes to swell, whereas more inert lipids have no effect (30). Lipid vesicles composed of DOPC
and filled with CF at a self-quenching concentration were
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Fig. 1. A: Psychosine and its enantiomer. B: Psy (open bars) is
degraded by GALC over time in normal MO3.13 cells, but ent-psy
(filled bars) is not. By 30 min after a lipid pulse, the amount of entpsy remaining in cells is significantly more than the amount of undigested psy. As expected, GALC is incapable of degrading the
enantiomer of its normal substrate. *P < 0.05.

Fig. 2. A: Both psy and ent-psy cause significant cell death in an
oliogodendrocytic cell line, MO3.13, at 20 M. Neither lipid induces cell death at 5 M. ent-Psy causes a small but significant increase in cell death compared with psy at 20 M. B: Both psy and
ent-psy induce apoptosis in a dose-dependent manner in MO3.13
cells. There is no statistical difference in the percentage of Annexin-V-positive cells after treatment with psy or ent-psy at any concentration tested.
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Fig. 3. Phospho-PKC translocation in response to platelet-derived growth factor (PDGF) after lipid exposure. Phospho-PKC (red) is normally intracellular (A). When cells are stimulated with PDGF, PKC translocates to the cell surface, where it is functionally active (B). Treatment with 10 M of psy (C) or ent-psy (D)
abolished the translocation of PKC to the cell surface. Plasma membrane is labeled with fluorescently conjugated cholera toxin b (green). This translocation was quantified by a blinded observer scoring randomly
selected cells as having membrane-associated or cytoplasmic p-PKC distribution (E). The percentage of cells
with membrane associated PKC was increased after PDGF compared with unstimulated cells (ⵑ60% vs.
ⵑ25%). Treatment with psy or ent-psy before PDGF stimulation reduced the percentage of cells with translocated PKC to approximately that of unstimulated cells. The amount of p-PKC (active) relative to total PKC
associated with the DRMs of lipid-treated cells was assessed. Treatment with psy or ent-psy inhibits the association of p-PKC with the DRMs (F, G).

exposed to psy at concentrations of 5, 20, and 50 M.
These concentrations of lipid are physiologically relevant
because they represent nontoxic, moderately toxic, and
extremely toxic levels of psy in this study, respectively. A

dose-dependent increase in fluorescence indicating liposome swelling was observed at all psy concentrations studied
(Fig. 4A). This was repeated with ent-psy, and, as expected,
the same result was observed (Fig. 4B).
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Cholesterol extractability
To investigate the effect of psy on the condition of the
plasma membrane, we used a cholesterol extractability
assay. The heptameric sugar molecule 2-hydroxyproyl-␤cyclodextrin (CD) is a large cyclic molecule capable of removing cholesterol from membranes (31). The extent to
and speed with which cholesterol is removed by CD can be
used to assess the environment of the membrane (31).
Cholesterol was significantly less extractable when cells
were treated with psy or ent-psy relative to the vehicle control (Fig. 5C). Several lipids with known effects on cholesterol extractability were tested as controls. As expected,
lysophosphatidylserine decreased extractability, 25-hydroxycholesterol increased extractability, and 1-palmitoyl-2-oleoylsn-glycero-3-phosphocholine had no effect on cholesterol
extractability (Fig. 5D). The total cholesterol of the cells was
unchanged across all treated groups (data not shown).

DISCUSSION

Distribution of Psy and ent-Psy
Psychosine accumulates in cholesterol-rich microdomains
and may have some effect on the protein composition of
these domains (14). We determined that ent-psy, like psy,
localizes to DRM microdomains in treated cells (Fig. 5A).
This was expected given the identical physical properties
of these two molecules.
DRM microdomain composition
Because psy is known to accumulate in Lubrol-resistant
membrane microdomains and to increase the percentage of cellular cholesterol there, we investigated whether
other lipids typically associated with these domains were
similarly altered. We found that several ceramide species
were significantly enriched in the detergent-resistant
fractions after psy or ent-psy exposure relative to vehicletreated cells (Fig. 5B). To account for any changes in absolute lipid concentration, the percentage of total cellular
ceramides found in the lubrol-resistant fractions is reported. The fraction of total cellular sphingomyelins found
in the DRMs was unchanged after psy or ent-psy exposure
(data not shown).
3308
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Fig. 4. A: Psy induces significant swelling in CF-loaded DOPC liposomes in a dose-dependent manner. The addition of psy at 5 M
(blue), 20 M (green), and 50 M (orange) caused disruption of
the liposomal membrane sufficient to allow water influx, which resulted in CF dequenching. B: Psy (green) and ent-psy (black) have
an indistinguishable effect on liposomes at 20 M. Both lipids
caused significant swelling and CF dequenching.

Much effort has been expended searching for the cellular pathway(s) or receptor(s) responsible for psy toxicity. One possibility that has been largely unrecognized,
however, is that psy may have a global and physicochemical effect on the membrane environment and little or no
direct binding to specific proteins. Indeed, several lines
of evidence would seem to suggest a membrane-based
toxicity mechanism. Psy causes hemolysis (32), causes the
inhibition of cytochrome c oxidase irrespective of the
protein’s orientation (33, 34), and has never been shown
to bind directly to any receptor or signaling protein despite significant investigation. Furthermore, a large number of proteins and cellular systems are affected by psy,
making the likelihood that psy directly interacts with every one of them unlikely. The enantiomer of psy, which
was recently synthesized (23), is a powerful probe to test
this possibility (19).
We first sought to confirm that ent-psy is not recognized
as a binding partner by the only known psy-binding protein, GALC. As expected, ent-psy is not recognized by GALC
and therefore is not degraded (Fig. 1B). This simple observation validates the use of ent-psy as a probe to investigate
the mechanism(s) of psy toxicity.
We observed that ent-psy has an equal or greater toxicity
profile to the natural lipid. This finding strongly supports
a nonenantio-specific mechanism for the majority of psy
toxicity because ent-psy is incapable of any enantio-specific
interactions with proteins that psy may have. Because it was
possible that the two lipids were causing cell death through
different pathways, we confirmed that both enantiomers
are initiating cell death at least in part through apoptosis,
as was previously reported for psy (10, 27, 28). In addition,
the failure of GALC to degrade ent-psy causes treated cells
to be exposed to a higher concentration of that lipid relative to psy. These data suggest a membrane perturbationbased mode of action for psy.
This is further supported by the finding that PKC, a
known psy-sensitive protein capable of directly binding lipids

(normally DAG and phospholipid such as phosphatidylserine), is equally inhibited by either enantiomer of psy.
Of all the proteins previously implicated in psy toxicity,
PKC was perhaps the most likely psy-binding candidate
given its two lipid binding domains. If psy bound to PKC
directly, one would expect that ent-psy should not interfere
with normal p-PKC localization and translocation because
that interaction should be stereo-specific and therefore unavailable to ent-psy. Therefore, the observation that ent-psy
still inhibits translocation argues that the defect preventing
translocation lies in the membrane, not within a PKC-lipid
complex. This is not a stimulation-dependent phenomenon because both psy and ent-psy reduce the amount of
p-PKC (active PKC) associated with the DRM even in a resting cell, consistent with previous reports (14). We believe
that this is further evidence supporting a perturbation in
membrane integrity after psy exposure. Disruption of membrane microdomains by other means have been shown to
alter PKC activity, further supporting this interpretation
(35). Although all known psy-sensitive proteins could not
be tested, given the fact that psy toxicity is nonenantio-selective, it is anticipated that many, if not most, psy-sensitive
proteins are affected in a similarly indirect manner.
These data do not exclude possible nonspecific lipidprotein associations. Therefore, it was vital to directly investigate the effect of psy on membranes. Through in vitro
experiments we observed that psy is indeed capable of affecting model membrane systems devoid of protein components, such as liposomes. Any effects observed in such a
system can only be due to the biophysical properties of the

lipid. Psy and its enantiomer altered bilayers of liposomes,
making them more water permeable and allowing the vesicles to expand their volume as the added sphingolipid
partitioned into the membrane (21, 36). It is clear that psy
and ent-psy alter the integrity of model membrane systems.
Given its enantio-insensitive toxicity, psy is likely deleterious to more complex cell membranes as well.
Even in the complex systems of whole cells, psy alters
the plasma membrane. psy reduces the extractability of
cholesterol from the membrane, demonstrating a clear alteration of normal membrane properties. Ent-psy affected
this measurement in an identical direction and magnitude
when compared with psy. This is consistent with previous
reports showing no change in total cholesterol in GLD
brains or psy-treated cells but an increased proportion of
total cholesterol in the raft fractions compared with nonraft
fractions (14). Because these DRMs are more condensed,
the cholesterol is likely protected from CD extraction in
these structures. Increased DRM cholesterol could be a result of favorable psy-cholesterol interactions (15), wherein
psy has affinity for the already cholesterol-rich DRM and
in turn stabilizes additional cholesterol within that domain. This is consistent with previous reports that a greater
percentage of total cellular cholesterol is located within the
detergent-resistant membrane domains from psy-treated
cells and the brains of GALC-deficient animals (14).
Because cholesterol localization had previously been reported to be altered after psy treatment, we investigated
whether other classic DRM lipids were similarly altered.
We found that several ceramide species were enriched in
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Fig. 5. A: ent-Psy partitions into DRMS (black), rather than detergent-soluble fractions (white), in the same
manner as psy. A slight increase in ent-psy concentration is observed, although the same quantity of lipid was
added to each cohort of cells. This is likely due to the lack of ent-psy degradation over the course of the experiment (Figure 2). B: A significant increase in the percentage of total cellular ceramides is found in the
DRMs of psy and ent-psy treated cells relative to vehicle controls, indicating an alteration of DRM composition after lipid exposure. Other classic DRM lipids (sphingomyelin) were unaffected, suggesting that this is
a specific phenomenon. C: Psy (closed squares) and ent-psy (open triangles) inhibit the extraction of cholesterol by CD from membranes of CHO cells. Significantly more 3H-cholesterol remains in the membranes of
psy or ent-psy treated cells after 4 min of exposure to CD-containing media. **P < 0.01. D: Control lipids LPC,
25-hydroxycholesterol, and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) decrease, increase,
and do not affect (respectively) cholesterol extraction from the membrane, as expected.
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great potential for treating GLD. These data also indicate
that any GLD therapies directed toward downstream effects
of psy toxicity, such as PKC activation, are likely to be only
modestly efficacious at best. Because membrane disruption is such a wide-reaching mechanism, multiple cascades
capable of inducing cell death are likely initiated. Targeting only one would likely be of limited benefit.
The lipid phase is increasingly appreciated as an active
player in cellular events originating at the membrane.
Changes in membrane properties can affect receptor functioning, protein-membrane associations, protein-protein
associations, as well as ion and small molecule gradients.
Perturbation of all of these cellular functions has been observed in cells exposed to psy or in GLD tissues. Membrane
composition and function is altered in a number of common
diseases, including Alzheimer’s (16), cancer (17), and diabetes (18). As our understanding of membrane organization and functionality improves, it is likely more diseases
may be added to this list.
The authors thank Doug Covey, Ph.D., for critical reading of
the manuscript and Stephanie Schneider for technical assistance
with the FACS analysis. Mass spectrometry analyses were
performed in Washington University Metabolomics Facility
and supported by P60 DK020579.
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